Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bevacizumab-alone Maintenance Treatment Progression”

3 trials

Showing 3 of 3 results

Large-scale testing (Phase 3)Study completedNCT00973609
What this trial is testing

Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)

Who this might be right for
Colorectal Neoplasms
AIO-Studien-gGmbH 853
Very early researchStudy completedNCT02802098
What this trial is testing

Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB in Advanced HER-2 Negative Breast Cancer

Who this might be right for
Metastatic Breast CancerBevacizumab-alone Maintenance Treatment Progression
Centro Nacional de Investigaciones Oncologicas CARLOS III 25
Large-scale testing (Phase 3)Study completedNCT00929240
What this trial is testing

Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 287

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation